On a special edition of the #BioCenturyThisWeek podcast, IQVIA Biotech CMO James Kyle Bryan joins BioCentury’s analysts to discuss technology trends on display at #AACR26, plus share his perspective on de-risking clinical development https://t.co/884XHaSVAK